NCT03429478

Brief Summary

Surgery induced sterile inflammation leaves behind a biomolecular footprint measurable by various pro-inflammatory markers e.g. IL-6, CD(Cluster of differentiation)19B, HsCRP(High-sensitivity CRP) etc. Music is a non-pharmacological means in attenuating this inflammatory pathway thereby improving Health related quality of life measurable by improved postoperative convalescence. Correct timing of music application is a lacuna in the knowledge. This research aims at evaluating the effect of preoperative music on sterile inflammation induced by index Laparoscopic Surgery (Laparoscopic Cholecystectomy) and its proposed beneficial effects on patient reported outcomes. A total of 50 patients divided into 2 groups (test and control) will be evaluated in this triple blind randomized controlled study aiming at evaluating the biomolecular signatures of sterile inflammatory response and its correlation with improved postoperative convalescence. All the patients will be followed up for a period of 1 month postoperatively to assess for overall improvement in health related quality of life. Collected data will be analysed using updated SPSS software and a p value of less than 0.05 will be taken as statistically significant in support of the measured indices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

November 27, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 12, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

December 27, 2019

Status Verified

December 1, 2019

Enrollment Period

2.1 years

First QC Date

November 27, 2017

Last Update Submit

December 26, 2019

Conditions

Keywords

MusicLaparoscopic SurgerySterile Inflammation

Outcome Measures

Primary Outcomes (4)

  • Postoperative Pain (POP)

    Visual Analogue Scale (VAS) will be used to measure the pain on a numeric scale of 0-100 at 6 Hours, Day 1, Day 3, Day 10 and Week 3 postoperatively respectively with a total of 5 readings. Higher values on the VAS will represent a worse outcome. Minimum value on VAS = 0 Maximum value on VAS= 100

    3 weeks

  • Postoperative Nausea Vomiting (PONV)

    Visual Analogue Scale (VAS) will be used to measure the PONV on a numeric scale of 0-100 at 6 Hours, Day 1, Day 3, Day 10 and Week 3 postoperatively respectively with a total of 5 readings. Higher values on the VAS will represent a worse outcome. Minimum value on VAS = 0 Maximum value on VAS= 100

    3 weeks

  • Postoperative Fatigue (POF)

    Visual Analogue Scale (VAS) will be used to measure the pain on a numeric scale of 0-100 at 6 Hours, Day 1, Day 3, Day 10 and Week 3 postoperatively respectively with a total of 5 readings. Higher values on the VAS will represent a worse outcome. Minimum value on VAS = 0 Maximum value on VAS= 100

    3 weeks

  • Gastrointestinal Quality of Life Index (GIQoL)

    Gastrointestinal Quality Of Life Index (GIQoL) 30 Days Min=0 (Best) Max=144 (Worst) GIQoL will be assessed on 30th postoperative day and any difference in the measurement will be assessed for analysis in between the two study arms.

    1 month

Secondary Outcomes (10)

  • Liver function test (LFT)

    upto 24 hours after surgical intervention

  • Serum amylase

    upto 24 hours after surgical intervention

  • Serum lipase

    upto 24 hours after surgical intervention

  • Interlukin-6 (IL-6)

    upto 24 hours after surgical intervention

  • Tumor Necrosis Factor-alpha (TNF -alpha )

    upto 24 hours after surgical intervention

  • +5 more secondary outcomes

Study Arms (2)

Music

EXPERIMENTAL

Preoperative application of a Bluetooth enabled headphones with standard music played for atleast 2 hours preoperatively.

Other: Preoperative application of a bluetooth enabled Headphones.

No Music

ACTIVE COMPARATOR

Preoperative application of a Bluetooth enabled headphones with no music played and headphones will just mask the surrounding noise.

Other: Preoperative application of a bluetooth enabled Headphones.

Interventions

A Bluetooth enabled Headphones device which is worn overhead and music can be played through it.

MusicNo Music

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age more than 18 years.
  • Should be able to understand and sign an informed consent.
  • Consent for surgery, anaesthesia and the use of standardized music before surgery. (Appendix I)
  • Fitness for General Anesthesia (GA)
  • Ability to maintain \& communicate a PRO diary.
  • Ability to communicate via telephone or email or SMS or WhatsApp.

You may not qualify if:

  • Fitfor GA but higher than ASA Grade I.
  • Uncontrolled coagulopathy
  • Suspicion of carcinoma gallbladder on USG
  • Any suspicion of common bile duct (CBD) stones or pancreatitis.
  • Patient using chronic anti-inflammatory drug.
  • Concomitant common bile duct (CBD) stone or any CBD intervention/pancreatitis in the preceding 6 weeks.
  • Patient on immunosuppressive / cytotoxic/ steroid therapy.
  • Documented or known sensitivity to any drug to be used in the study protocol.
  • Pregnant or lactating ladies.
  • Any concomitant surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prof. Brij Bushan Agarwal

Delhi, 110058, India

Location

MeSH Terms

Conditions

CholecystitisCholelithiasisIntraoperative Complications

Condition Hierarchy (Ancestors)

Gallbladder DiseasesBiliary Tract DiseasesDigestive System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The Participants will be randomized to be part of the study groups. The Care providers will not be aware of the grouping of the participants as the intervention is done in the pre-operative holding area. All patients will undergo Laparoscopic Cholecystectomy under standard operative and anesthesia protocol. The Investigator (Nurse and the doctor staff) will also be unaware of the grouping of the patients. The recorded data will be analyzed by an individual outcome asser unaware of the grouping or identity of the patient.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: 50 patients meeting the inclusion criteria will be included in the study after written and informed consent. They will be randomized and divided into 2 groups. Group 1 will be labelled as intervention group (recieving pre-operative music intervention), The group 2 will be labelled as controlled group (Not receiving pre-operative music intervention). Clinico-biochemical, Bio-cellular \& Neurohumoral data evaluation will be done in both the groups.The results will be analyzed using standard SPSS software.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice Chairman Department of General and Laparoscopic Surgery

Study Record Dates

First Submitted

November 27, 2017

First Posted

February 12, 2018

Study Start

November 1, 2017

Primary Completion

November 30, 2019

Study Completion

December 1, 2019

Last Updated

December 27, 2019

Record last verified: 2019-12

Locations